Therapeutic Solutions International Inc.

Aug 11, 2020

Therapeutic Solutions International Launches Campbell Neurosciences Division aimed at Biologically Identifying and Repairing Suicide-Prone Brains

Jun 22, 2020

Therapeutic Solutions International Announces Intention to Use Clinical Stage NK Activating Cancer Immunotherapy for COVID-19

Jun 15, 2020

Therapeutic Solutions International Issues "NOT US" Notice to Shareholders

Jun 15, 2020

Therapeutic Solutions International Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune(TM) in Animal Studies

Jun 11, 2020

Therapeutic Solutions International Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer

Jun 04, 2020

Therapeutic Solutions International Announces Positive Preclinical and Clinical Evaluation of Nutritional Supplement QuadraMune(TM), Designed to Protect Against COVID-19

Jun 01, 2020

San Diego Top Doctor Collaborates with Therapeutic Solutions International to Report QuadraMune(TM) Immune Boosting Data in Clinical Trial

May 12, 2020

San Diego "Top Doctor" James Veltmeyer Collaborates With Therapeutic Solutions International in Cord Blood Based Immunotherapy for COVID-19 Damaged Lungs

May 05, 2020

Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical Candidate: QuadraMune(TM)